Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

<< Previous
Bullboard Posts
Next >>
Post by prophetoffactzon Jan 06, 2024 7:06pm
120 Views
Post# 35814145

NASDAQ with Raymond James analyst coverage?

NASDAQ with Raymond James analyst coverage?"Aeterna has engaged Raymond James Ltd. as its financial advisor..."

Raymond James(Wikepedia):
Revenue Increase US$11.0 billion (2022)
2,022,000,000 United States dollar (2022) 
Increase US$1.51 billion (2022)
Total assets Increase US$173.8 billion (2022)
Total equity Increase US$9.34 billion (2022)
Number of employees
c. 8,700 (September 2022)

About our client

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology ELUTYX™. 

About our client

Bluebird bio is a biotechnology company committed to researching, developing, and commercializing potentially curative transformative gene therapies for severe genetic diseases based on their lentiviral vector (LVV) gene addition platfor

About our client

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating d


<< Previous
Bullboard Posts
Next >>